| Drug Name |
Procarbazine hydrochloride |
| Drug ID |
BADD_D01847 |
| Description |
An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease. |
| Indications and Usage |
For use with other anticancer drugs for the treatment of stage III and stage IV Hodgkin's disease. |
| Marketing Status |
approved; investigational |
| ATC Code |
L01XB01 |
| DrugBank ID |
DB01168
|
| KEGG ID |
D00478
|
| MeSH ID |
D011344
|
| PubChem ID |
9703
|
| TTD Drug ID |
D08GYO
|
| NDC Product Code |
48087-0085; 14096-128; 54482-054; 48087-0050 |
| UNII |
XH0NPH5ZX8
|
| Synonyms |
Procarbazine | Procarbazine Monohydrobromide | Monohydrobromide, Procarbazine | Procarbazine Hydrochloride | Hydrochloride, Procarbazine | Procarbazine Monohydrochloride | Monohydrochloride, Procarbazine | Matulane | Natulan |
